Lieke H. J. Simkens

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

Lieke H. J. Simkens, Harm van Tinteren, Anne M. May et al. · The Lancet · 2015 · 528 citations

Medicine, Oncology, Pharmacology +13

Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy

Yvonne L.B. Klaver, Lieke H. J. Simkens, V.E.P.P. Lemmens et al. · European Journal of Surgical Oncology · 2012 · 188 citations

Medicine, Oncology, Surgery +14

Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients

Sophie A. Kurk, Petra H.M. Peeters, Rebecca K. Stellato et al. · Journal of Cachexia Sarcopenia and Muscle · 2019 · 106 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer

Sjoerd T. Ligthart, Frank Coumans, François‐Clément Bidard et al. · PLoS ONE · 2013 · 99 citations · Full text

Medicine, Oncology, Pathology +17

Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy

Lieke H. J. Simkens, Miriam Koopman, Linda Mol et al. · European Journal of Cancer · 2011 · 96 citations · Full text

Medicine, Oncology, Surgery +14